A specialist, cohort-driven approach to investing—combining venture building, global partnerships, and aligned capital to scale companies from Australia to global markets.

With several cycles of venture capital ecosystem experience as founders, technologists, counsel, and now venture capitalists. We founded a venture studio (focused Australia to US deep technology), which worked for government, science agencies, and corporations; we continue this work, as a Labs group. While we have been investing through the operating company from the onset, and through aligned investment entities; we started CVC investing directly in Australia in April 2025, and extend our 2024 partnership, achieving exits during that time.

Our capital is aligned in specialist fashion, through cohorts that look to track record, geographic and specialists learning, as well as CVC participation. Our fast build and step wise scale thesis Australia outbound is seeing at least 4 exits among a portfolio of 15 and moving fast.

We profile the stories of some of the venture builds that encompass innovation work, venture build, and investment, though we may not have invested in every case. We offer through the CVC at a stage of venture build with partners, although two paths may take place, where we may not participate, either the valuation metrics are beyond our risk threshold or the company goes to acquisition or exit, ahead of our schedule.

At present the vehicles that may invest are our own CVC and partners, ASV BNE Longhorn Partners, and US partnership and LPs. We do not entertain direct solicitation for investment rather working through specialists GP cohorts and CVCs. In so doing, we hope to build out a specialist thesis, measured, quick moving, with built in specialist knowledge, Labs support for engineering and resourcing, and CVC distribution and technical support.